万古霉素-庆大霉素预制间隔器在慢性髋膝关节假体周围感染二期翻修中的再植入微生物学与结局
该回顾性队列研究纳入2010至2017年因慢性髋或膝假体周围感染行二期翻修翻修术并使用万古霉素-庆大霉素预制骨水泥间隔器的108例患者(61髋、47膝),评估二期再植入时微生物培养阳性与治疗失败的关系。结果显示22.2%患者至少1个二期培养阳性,9.3%至少2个样本阳性,平均随访46.4个月总体成功率77.8%,培养阳性者治疗失败率更高(15.5% vs 45.8%,P < .01)。糖尿病是二期培养阳性的危险因素(P = .03),而间隔器固定时使用额外抗生素骨水泥显示保护作用(P < .01)。
要点
- 二期翻修使用万古霉素-庆大霉素预制间隔器时,22.2%患者至少1个二期培养阳性,9.3%至少2个样本阳性。
- 平均随访46.4个月总体成功率为77.8%,培养阳性者治疗失败率更高(15.5% vs 45.8%,P < .01)。
- 糖尿病是二期培养阳性的危险因素(P = .03),间隔器固定时使用额外抗生素骨水泥显示保护作用(P < .01)。
核心结论
- 使用万古霉素-庆大霉素骨水泥间隔器时,二期培养阳性与更高的治疗失败率相关。
- 糖尿病增加二期培养阳性的可能性。
- 第一期使用额外抗生素骨水泥固定间隔器显示保护作用。
研究设计与样本
- 回顾性队列研究,纳入2010至2017年因慢性髋或膝假体周围感染行二期翻修翻修术的患者。
- 共108例,其中髋61例、膝47例,间隔器阶段使用万古霉素-庆大霉素预制骨水泥间隔器。
- 评估第一和第二期术后术中微生物培养结果,主要终点为感染根除或复发。
主要发现
- 22.2%患者至少1个二期培养阳性,9.3%至少2个样本阳性。
- 平均随访46.4个月,总体成功率为77.8%。
- 培养阳性病例治疗失败率更高(15.5% vs 45.8%,P < .01),与阳性样本数量无关。
- 糖尿病是二期培养阳性的危险因素(P = .03)。
- 间隔器固定时使用额外抗生素骨水泥显示保护作用(P < .01)。
关键数值与推荐
- 二期培养阳性定义为至少1个术中培养阳性,22.2%患者满足;至少2个样本阳性者占9.3%。
- 治疗失败率:培养阳性组45.8% vs 培养阴性组15.5%(P < .01)。
- 糖尿病与二期培养阳性相关(P = .03)。
- 额外抗生素骨水泥用于间隔器固定与二期培养阳性风险降低相关(P < .01)。
临床怎么用
- 对于使用万古霉素-庆大霉素预制间隔器行二期翻修的慢性髋或膝假体周围感染患者,二期培养阳性与更高治疗失败率相关。
- 糖尿病患者二期培养阳性可能性增加。
- 第一期使用额外抗生素骨水泥固定间隔器可能显示保护作用。
局限性
- 原文未述局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Second-stage positive cultures in 2-stage revision arthroplasty are a matter of concern, as their influence in outcomes is not clearly defined. We sought to study reimplantation microbiology when using vancomycin-gentamicin prefabricated cement spacers in hip and knee periprosthetic joint infection. The associations of second-stage positive cultures with treatment failures and patient-associated factors were analyzed. METHODS: We conducted a retrospective cohort study, examining patients managed with 2-stage revision arthroplasty due to knee or hip chronic periprosthetic joint infection between 2010 and 2017. Prefabricated vancomycin-gentamicin cement spacers were used during the spacer stage. Intraoperative microbiological culture results after the first and second stages were evaluated. The primary end point was infection eradication or relapse. RESULTS: A total of 108 cases were included (61 hips and 47 knees). And 22.2% of patients had ≥1 second-stage positive culture, while 9.3% had ≥2 positive samples. Overall success, at an average follow-up of 46.4 months, was 77.8%. Treatment failure was higher among cases with positive cultures (15.5% vs 45.8%, P < .01) regardless of the number of positive samples. Diabetes was identified as a risk factor for second-stage positive cultures (P = .03); use of cement loaded with extra antibiotics for spacer fixation showed a protective effect (P < .01). CONCLUSION: Second-stage positive cultures were related to a higher failure rate when using vancomycin-gentamicin cement spacers. Diabetes increased the likelihood of second-stage positive cultures. The use of extra-antibiotic-loaded cement for spacer fixation during the first stage showed a protective effect.
引用
- Corró S, Vicente M, Rodríguez-Pardo D, et al. Vancomycin-Gentamicin Prefabricated Spacers in 2-Stage Revision Arthroplasty for Chronic Hip and Knee Periprosthetic Joint Infection: Insights Into Reimplantation Microbiology and Outcomes. J Arthroplasty. 2019. PMID: 31530462. doi:10.1016/j.arth.2019.07.043
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。